B Elliot, I Aromin, R Gold, T Flanigan, M Mileno. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AIDS-Related Opportunistic Infections/drug therapyAIDS-Related Opportunistic Infections/immunologyAdultAnti-HIV Agents/therapeutic useCD4 Lymphocyte CountDidanosine/therapeutic useDrug Therapy, CombinationHIV Protease Inhibitors/therapeutic useHumansIndinavir/therapeutic useLeukoencephalopathy, Progressive Multifocal/complicationsLeukoencephalopathy, Progressive Multifocal/drug therapyLeukoencephalopathy, Progressive Multifocal/immunologyMaleTime FactorsZidovudine/therapeutic use
Substances: See more » Anti-HIV AgentsHIV Protease InhibitorsZidovudineIndinavirDidanosine
Year: 1997 PMID: 9121266 DOI: 10.1016/S0140-6736(05)61753-9
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321